Latest Insider Transactions at Nuvation Bio Inc. (NUVB)
This section provides a real-time view of insider transactions for Nuvation Bio Inc. (NUVB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuvation Bio Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuvation Bio Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2021
|
David Hung PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
58,645,012
+26.65%
|
$586,450,120
$10.0 P/Share
|
|
Feb 10
2021
|
Omega Fund V, L.P. > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+1.74%
|
$5,000,000
$10.0 P/Share
|
|
Feb 10
2021
|
Omega Fund V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
8,130,097
+22.68%
|
-
|
|
Feb 10
2021
|
Oleg Nodelman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
10,082,017
+38.77%
|
$40,328,068
$4.0 P/Share
|
|
Feb 10
2021
|
Oleg Nodelman Director |
BUY
Conversion of derivative security
|
Indirect |
2,775,000
+46.72%
|
-
|
|
Jul 06
2020
|
Eco R1 Panacea Holdings, LLC Director |
BUY
Open market or private purchase
|
Direct |
390,000
+50.0%
|
$3,900,000
$10.0 P/Share
|
|
Feb 10
2020
|
W Anthony Vernon |
BUY
Grant, award, or other acquisition
|
Direct |
304,100
+32.06%
|
$3,041,000
$10.0 P/Share
|